Gliomas are essential mind tumors that are thought to get from neuroglial stem or forebear cells. Based on their histological appearance, they have been generally delegated astrocytic, oligodendroglial or ependymal tumors and relegated WHO grades I–IV, which show various levels of danger. Gigantic advancement in genomic, transcriptomic and epigenetic profiling has brought about new ideas of arranging and treating gliomas. Diffusely invading gliomas in grown-ups are presently isolated into three overall tumor bunches with particular normal chronicles, reactions to therapy and results: isocitrate dehydrogenase (IDH)- freak, 1p/19q co-erased tumors with generally oligodendroglial morphology that are related with the best visualization; IDH-freak, 1p/19q non-co-erased tumors with for the most part astrocytic histology that are related with transitional result; and IDH wild-type, for the most part higher WHO grade (III or IV) tumors that are related with helpless guess. Gliomas in youngsters are atomically particular from those in grown-ups, the lion's share being WHO grade I pilocytic astrocytomas described by encompassed development, good anticipation and incessant BRAF quality combinations or transformations. Ependymal tumors can be atomically partitioned into particular epigenetic subgroups as indicated by area and visualization.